📰 Pharma Services News
Page 18 - Pharma Services News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Services. Real-time updates on events, politics, business and more.
April 28, 2023
Huang brings decades of expertise to MassBio Board to aid in organizational mission...
April 25, 2023
/PRNewswire/ -- MarketsandMarkets, a leading market research organization, is pleased to announce the venue details for its 8th Annual High Potent Medicines...
April 25, 2023
The company acquires three automated sterile fill-finish machines for its facilities in San Diego and Melbourne, which are now fully operational.
April 20, 2023
Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities...
April 19, 2023
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced that three new state-of-the-art automated sterile fill-finish machines at its San Diego and Melbourne facilities are now fully operational. The innovative machinery from Cytiva can be used to fill various sterile medications into vials and syringes for small-to-mid scale client needs.
April 18, 2023
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced that three new...
April 18, 2023
New equipment added to San Diego and Melbourne facilities will help with clinical scale and global capacity shortages
April 17, 2023
PCI Pharma Services will break ground on a $50 million facility this year. Learn whats coming and what kind of impact that will have.
April 17, 2023
NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) has been given a consensus recommendation of “Moderate Buy” by the thirteen analysts that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and eight have issued a buy recommendation on the company. The average […]
April 17, 2023
NeoGenomics (NASDAQ:NEO – Get Rating) issued an update on its FY 2023 earnings guidance on Friday morning. The company provided earnings per share guidance of -$0.38–$0.32 for the period, compared to the consensus earnings per share estimate of -$0.44. The company issued revenue guidance of $545.00 million-$555.00 million, compared to the consensus revenue estimate of […]